The Friends and Family Test (FFT) is an important feedback tool that supports the fundamental principle that people who use NHS services should have the opportunity to provide feedback on their experience. Listening to the views of patients and staff helps identify what is working well, what can be improved and how.

We collect your Friends and Family responses via Microsoft Forms. Patients are sent text messages with a URL to our FFT Form. You can submit your responses by using the QR code below. This is also displayed in the Practice Waiting Room.

• In March 2024, we received 62 responses.  94% said that the service received had been good or very good. 
• In February 2024, we received 64 responses.  86% said that the service received had been good or very good. 
• In January 2024, we received 79 responses. 86% said that the service received had been good or very good.
• In December 2023, we received 54 responses. 92% said that the service received had been good or very good.

DEFINE

Determining the Effectiveness of a FeNO-guided asthma management INtervEntion in primary care (DEFINE) is a research study conducted by the University of Oxford. Its aim is to help health care professionals in GP surgeries provide a more personalised approach to managing patients’ asthma by using FeNO to guide decisions about their treatment.
FeNO stands for fractional exhaled nitric oxide and is measured using a simple breath test.

Nitric oxide is a gas which everyone breathes out. People with inflamed airways breathe out more nitric oxide than people whose airways are not inflamed. These patients are more likely to have an asthma attack if their inflammation remains untreated.
FeNO is already measured in patients with severe asthma who are seen in hospital clinics. However, very few GP surgeries routinely use FeNO to help them monitor treatment.

A copy of the Research Information Sheet can be found below:

Participant Information Leaflet for patients aged 16 years and older

Participant Information Leaflet for parents/guardians of patients aged 12 to 15 years